0001373604-25-000084.txt : 20250530 0001373604-25-000084.hdr.sgml : 20250530 20250530174038 ACCESSION NUMBER: 0001373604-25-000084 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20250528 FILED AS OF DATE: 20250530 DATE AS OF CHANGE: 20250530 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Leonard Braden Michael CENTRAL INDEX KEY: 0001373603 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-41331 FILM NUMBER: 251012472 MAIL ADDRESS: STREET 1: 156 S. FIRST STREET CITY: ZIONSVILLE STATE: IN ZIP: 46077 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: AN2 Therapeutics, Inc. CENTRAL INDEX KEY: 0001880438 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences EIN: 820606654 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 1800 EL CAMINO REAL, SUITE D CITY: MENLO PARK STATE: CA ZIP: 94027 BUSINESS PHONE: (650) 331-9090 MAIL ADDRESS: STREET 1: 1800 EL CAMINO REAL, SUITE D CITY: MENLO PARK STATE: CA ZIP: 94027 4 1 form4.xml X0508 4 2025-05-28 0001880438 AN2 Therapeutics, Inc. ANTX 0001373603 Leonard Braden Michael 65 E CEDAR - SUITE 2 ZIONSVILLE IN 46077 true false Common Stock 2025-05-28 4 S 0 2000000 1.16 D 3749432 I Holding of BML Investment Partners, L.P. Common Stock 2025-05-28 4 S 0 100000 1.16 D 3649432 I Holding of BML Investment Partners, L.P. Common Stock 2025-05-30 4 S 0 425000 1.01 D 3224432 I Holding of BML Investment Partners, L.P. Common Stock 2025-05-30 4 S 0 7000 1.0324 D 3217432 I Holding of BML Investment Partners, L.P. BML Capital Management, LLC ("BML Capital") serves as the general partner of BML Investment Partners, L.P., a Delaware limited partnership (the "Fund"), which is the direct owner of the subject shares. Mr. Leonard is the managing member of BML Capital, and exercises investment and voting control over the subject shares. Accordingly, shares owned directly by the Fund may be regarded as being beneficially owned by Mr. Leonard. Notwithstanding, Mr. Leonard disclaims beneficial ownership of such shares, except to the extent of his pecuniary interest therein. The shares were sold in multiple transactions at an average price of $1.0324. Braden Michael Leonard 2025-05-30